FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

BALPHARMA

46.15
-0.8 (-1.7%)
Updated 03:29 04/08 IST

BALPHARMA Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for BALPHARMA
Disclaimer
0% Bullish
0% Bearish

BALPHARMA Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See BALPHARMA Share Price Targets >>

BALPHARMA Ratings

Long term BALPHARMA rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live BALPHARMA message board: Is BALPHARMA buy or sell? Should I buy BALPHARMA shares? Why are BALPHARMA shares falling? Should I invest in BALPHARMA stock?

  1. Home
  2. BALPHARMA Forum

BALPHARMA Share Price Discussion

M
Reputation: 5,886 • Jun 10 6:40 AM

Type
Buy
Instrument
BALPHARMA
Entry Price
₹42.95
Price@Trade
₹42.95
Target Price
₹100
Stop Price
₹20
Valid Till
Jul 10, 2020 3:20 AM
Margin
₹42,950 approx for 1000 Qty
Status
Active
Like
Reply
D
Reputation: 2,221 • Jan 14 7:52 AM

Watch
Btst + positional
Buy bal pharma cash
48.2-42.2
Sl 40.5
Tgt 55.5/60++
Based on Short-term breakout levels
Like
Reply (2)
Latest replies
DREAM BIG VIEW @dreambig
Jan 14 8:26 AM

Bal pharma made new day high
48.8💸
DREAM BIG VIEW @dreambig
Jan 14 8:38 AM

49.1💸💸💸new day high
N
Reputation: 3,388 • Aug 28, 2019 1:38 AM
Stocks in the news: HUL, IDBI Bank, Oberoi Realty, Power Grid, Dilip Buildcon, DHFL
IDBI Bank | Oberoi Realty | Power Grid Corporation | Dilip Buildcon | DHFL | Nalco and Premier Explosives are stocks which are in the news today.
Moneycontrol
Like
Reply
N
Reputation: 3,388 • May 31, 2019 11:18 AM
Like
Reply

*BIG BUY BAL PHARMA*

*CMP 72.50*

*TG 78/80/82*

*SL 67*
2
Reply (11)
Latest replies
RJ ROCKET TRADES @RISHABHTYAGI
Apr 26, 2019 4:14 AM

**Bal pharma above 76 more blast coming up**
RJ ROCKET TRADES @RISHABHTYAGI
Apr 26, 2019 4:15 AM

**76 broken guys now 80 coming up guys balpharda**
RJ ROCKET TRADES @RISHABHTYAGI
Apr 26, 2019 4:20 AM

**BALPHARMA GUYS 78.30 FROM 72.50
T1 HIT IN 15 MINS

BIG BREAKOUT IN THE SCRIP

UP BY 11.50%**
RJ ROCKET TRADES @RISHABHTYAGI
Apr 26, 2019 4:24 AM

**NEXT BREAKOUT LEVEL OF BALPHARMA ABOVE 78 GATES OPEN UPTO 80-85**
RJ ROCKET TRADES @RISHABHTYAGI
Apr 26, 2019 4:34 AM

**8.5 % RETURN IN BALPHARMA IN INTRADAY😍😍**
S
Reputation: 2,316 • Mar 5, 2019 3:46 AM

One of midcap pharma favorite counter. Making base @65-70 zones add till 67-69 in dips for targets 89-98-120. In 2 months approx. Positive till hold 60 closing basis.

Disclaimer-educational purpose only.
BALPHARMA - 100453
Like
Reply
Like
Reply (1)
Latest replies
Portfolio Busters @kishorKanase
Dec 14, 2018 3:37 AM

BAL PHARMA💋85💋

From 83.. +2pts.. Gain..🥳🥳🥳🤩🤩🥳🥳
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • BALPHARMA - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization99.9
    Enterprise Value192.63
    Price to Earnings18.42
    Price to Book Value1.3
    Return on Capital Employed0.11
    Return on Equity0.08
    Face Value10
    Dividend Yield0.01
  • BALPHARMA Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 449.549.544.9546.3
    Aug 343.0547.1542.546.95
    Jul 3141.143.83942.9
    Jul 3043.343.34141.1
    Jul 2943.844.84243.3
  • BALPHARMA Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹42.75
    30 Day Moving Average₹43.42
    50 Day Moving Average₹42.28
    100 Day Moving Average₹40.04
    200 Day Moving Average₹40.85
  • BALPHARMA - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue207.66225.96-0.08
    Operating Profit22.7819.590.16
    Profit Before Tax8.458.070.05
    Net Income5.944.970.2
  • BALPHARMA - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds76.8672.230.06
    Total Liabilities180.29171.50.05
    Total Assets257.15243.730.06
  • BALPHARMA - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity5.945.460.09
    Cash from Investing Activity-10.06-7.590.33
    Cash from Financing Activity3.532.280.55
    Net Cash Flow-0.590.15-4.93
  • BALPHARMA - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.020.02
    Return on Equity0.080.07
    Return on Capital Employed0.110.12
  • BALPHARMA - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.11
    3 Year CAGR Growth in Operating Profit0.3
    3 Year CAGR Growth in EBIDTA0.3
    3 Year CAGR Growth in Net Income0.48
    3 Yr CAGR Growth - Diluted EPS0.34
  • BALPHARMA - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.4
    5 Year CAGR Growth in Operating Profit0.32
    5 Year CAGR Growth in EBIDTA0.37
    5 Year CAGR Growth in Net Income0.39
    3 Yr CAGR Growth - Diluted EPS0.03
  • BALPHARMA - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 28, 2019 1:38 AM
    Stocks in the news: HUL, IDBI Bank, Oberoi Realty, Power Grid, Dilip Buildcon, DHFL
    Moneycontrol
    NewsBot
    May 31, 2019 11:18 AM
    NewsBot
    Apr 5, 2019 3:48 AM
    NewsBot
    Feb 13, 2019 11:42 AM
    NewsBot
    Dec 3, 2018 5:32 AM
  • BALPHARMA - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020